Skip to Content

Nuvigil Approval History

  • FDA approved: Yes (First approved June 15th, 2007)
  • Brand name: Nuvigil
  • Generic name: armodafinil
  • Dosage form: Tablets
  • Company: Cephalon, Inc.
  • Treatment for: Narcolepsy

Nuvigil (armodafinil) is a non-amphetamine wake-promoting agent for the treatment of excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome (OSAHS), narcolepsy, and shift work sleep disorder (SWSD).

Development History and FDA Approval Process for Nuvigil

Jun 18, 2007Approval Cephalon Receives FDA Approval of Nuvigil for the Treatment of Excessive Sleepiness Associated with Three Disorders
Apr  2, 2007Cephalon Provides Update Related to Nuvigil New Drug Application
Nov  7, 2006Cephalon Inc. Granted Composition of Matter Patent Covering Nuvigil
May  1, 2006Cephalon Receives Approvable Letter for Nuvigil
Mar 31, 2005Cephalon Files New Drug Application for Nuvigil

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.